Added to YB: 2025-08-08
Pitch date: 2025-08-06
HIMS [neutral]
Hims & Hers Health, Inc.
-69.44%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$3.7B
Pitch Price
$51.76
Price Target
N/A
Dividend
N/A
EV/EBITDA
23.63
P/E
30.31
EV/Sales
1.90
Sector
Health Care Providers and Services
Category
growth
Hims & Hers Q2’25: The Good and the Bad
HIMS (earnings update): Q2'25 revenue $545M (+73% YOY) but -7% QoQ due to GLP-1 sales drop ($190M vs $230M Q1). Core business stagnant at $355M. Net income +220% to $43M, but cash flow negative $19M. Growth strategy: global expansion, blood tests (cancer diagnostics TAM $109B), and longevity peptides.
Read full article (7 min)